Acute Assessment 2. Cardiovascular System Guidelines
Anticoagulation Guidance
DOAC Decision Aid Tool (July 2022)
Summary of considerations when prescribing a DOAC
BNSSG Guidance on switching between oral anticoagulants (July 2022)
NBT DOAC counselling checklist (Oct 2013; under review; expected summer 2022)
UHB Anticoagulants counselling (Nov 2020; under review; expected summer 2022)
Management of Subtherapeutic INRs in the community
Anticoagulation Patient Information
Apixaban
-
Apixaban - A guide for patients with Atrial Fibrillation (available in 12 non-English languages)
Dabigatran
Edoxaban
-
Patient booklet for patients with NVAF prescribed Edoxaban (available in 9 non-English languages)
Rivaroxaban
-
Support for Patients with Atrial Fibrillation (available in 10 non-English languages)
-
Step 1 – Go to the following web address https://www.xarelto.co.uk/patients-atrial-fibrillation
-
Step 3 – Pick the required language
-
Antiplatelet Guidance
Antiplatelet Guidelines March 2021 BNSSG
Heart Failure Guidance
Primary Care Heart Failure Treatment Guideline
Practical Guidance on how to use Heart Failure Medications
Traffic light: How to monitor renal function and potassium rises in stable Heart Failure
See 'Endocrine System Guidelines' page for the 'Advice on the use of SGLT-2 inhibitors in Type 2 Diabetes, Heart Failure and Chronic Kidney Disease'
Lipid Guidance
BNSSG Management of Blood Lipid Levels
Inclisiran Clinical Guidelines
Inclisiran Information for Primary Care
AAC/NHSE Statin Intolerance Pathway